Heather Griffith
Nurse Practitioner · du Bois, PANPI 1508205519
Payments from drug & device makers
Across 158 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$511
- AbbVie$291
- Pfizer$227
- Lilly USA, LLC$179
- Exact Sciences$178
- Abbott$164
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,737100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 29 | $511 |
| AbbVie(2 entities) | 16 | $291 |
| Pfizer | 14 | $227 |
| Lilly USA, LLC | 11 | $179 |
| Exact Sciences | 9 | $178 |
| Abbott | 8 | $164 |
| Amgen | 10 | $156 |
| GSK | 7 | $105 |
| Shield Therapeutics Inc | 6 | $104 |
| Boehringer Ingelheim | 5 | $90 |
| Daiichi Sankyo Inc. | 5 | $85 |
| Philips North America LLC | 5 | $80 |
| Verona Pharma, Inc. | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 4 | $60 |
| Xeris Pharmaceuticals, Inc. | 3 | $57 |
| Alkermes, Inc. | 2 | $50 |
| AstraZeneca | 3 | $47 |
| Merck | 3 | $43 |
| Sobi, Inc | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $29 |
| Johnson & Johnson | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Bayer | 1 | $19 |
| Biogen | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Stryker | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$2,737 in reported general payments places this provider in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $63,863 |
| EliquisApixaban | 72 | $53,792 |
| JardianceEmpagliflozin | 61 | $52,736 |
| TrulicityDulaglutide | 26 | $34,108 |
| TradjentaLinagliptin | 49 | $30,866 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $30,019 |
| JanuviaSitagliptin Phosphate | 30 | $23,857 |
| RybelsusSemaglutide | 26 | $23,665 |
| WegovySemaglutide | 17 | $20,935 |
| Victoza 3-PakLiraglutide | 18 | $16,057 |
| LinzessLinaclotide | 24 | $15,085 |
| XareltoRivaroxaban | 20 | $13,717 |
| MyrbetriqMirabegron | 24 | $11,784 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 59 | $9,131 |
| OxycontinOxycodone Hcl | 23 | $9,012 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Wegovy | $511 | $108,46493 claims |
| Boehringer IngelheimJardiance, Tradjenta | $90 | $83,602110 claims |
| PfizerEliquis | $227 | $53,79272 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $105 | $41,11368 claims |
| Lilly USA, LLCTrulicity | $179 | $34,10826 claims |
| MerckJanuvia | $43 | $23,85730 claims |
| AbbVieLinzess, Synthroid | $291 | $17,24477 claims |
| Johnson & JohnsonXarelto | $21 | $13,71720 claims |
| Astellas Pharma US IncMyrbetriq | $29 | $11,78424 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in du Bois
- Jean Levindu Bois$15K
- Todd Sudikdu Bois$11K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.